Your browser doesn't support javascript.
loading
Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients.
Baron, Frédéric; Canti, Lorenzo; Ariën, Kevin K; Kemlin, Delphine; Desombere, Isabelle; Gerbaux, Margaux; Pannus, Pieter; Beguin, Yves; Marchant, Arnaud; Humblet-Baron, Stéphanie.
Afiliação
  • Baron F; Laboratory of Hematology, GIGA-I3, University of Liege and Centre Hospitalier Universitaire (CHU) of Liège, Liege, Belgium.
  • Canti L; Department of Medicine, Division of Hematology, Centre Hospitalier Universitaire (CHU) of Liège, Liège, Belgium.
  • Ariën KK; Laboratory of Hematology, GIGA-I3, University of Liege and Centre Hospitalier Universitaire (CHU) of Liège, Liege, Belgium.
  • Kemlin D; Virology Unit, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.
  • Desombere I; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
  • Gerbaux M; Department of Nephrology, Dialysis and Renal Transplantation, Hôpital Erasme, Université libre de Bruxelles, Brussels, Belgium.
  • Pannus P; Scientific Directorate Infectious Diseases in Humans, Sciensano, Brussels, Belgium.
  • Beguin Y; Institute for Medical Immunology and ULB Center for Research in Immunology (U-CRI), Université libre de Bruxelles (ULB), Gosselies, Belgium.
  • Marchant A; Department of Microbiology, Immunology and Transplantation, Laboratory of Adaptive Immunology, KU Leuven, Leuven, Belgium.
  • Humblet-Baron S; Scientific Directorate Infectious Diseases in Humans, Sciensano, Brussels, Belgium.
Front Immunol ; 13: 827242, 2022.
Article em En | MEDLINE | ID: mdl-35309332
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica